Serengeti Asset Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Serengeti Asset Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-1,750,000	Closed	-$543K	–	59
2014 Q1	$543K	Sell	1,750,000 -350,000	-17%	-$130K	0.05%	41
2013 Q4	$714K	Buy	2,100,000 +865,000	+70%	+$1.05M	0.06%	46
2013 Q3	$2.5M	Sell	1,235,000 -465,000	-27%	-$886K	0.31%	37
2013 Q2	$3.23M	Buy	+1,700,000	New	+$2.99M	0.33%	42

Other funds holding GCVRZ

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

CPM

Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Serengeti Asset Management's GCVRZ Position: Q2 2014 in Review

Serengeti Asset Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2014, closing a stake of 1,750,000 shares — an estimated $543K sold.

Serengeti Asset Management first reported a position in GCVRZ in Q2 2013 and held it in 4 quarters. The position peaked at $3.23M in Q2 2013. 124 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2014.

Serengeti Asset Management reported no remaining Sanofi Contingent Value Rights position as of Q2 2014 after selling out during the quarter.
Serengeti Asset Management sold 1,750,000 Sanofi Contingent Value Rights shares in Q2 2014, an estimated $543K.
Serengeti Asset Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 4 quarters.
Serengeti Asset Management's Sanofi Contingent Value Rights position peaked at $3.23M in Q2 2013.
124 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2014.

Based on Serengeti Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.